BACKGROUND: Optimization of atrioventricular (AV) and interventricular (VV) intervals may improve cardiac resynchronization therapy (CRT) response but is a complex task. Fusion with intrinsic conduction may increase the benefit of CRT. The aim was to describe fusion-optimized intervals (FOI), a new method of optimizing CRT based on QRS duration. METHODS AND RESULTS: Seventy-six consecutive patients with preserved AV conduction who received CRT were prospectively included. The AV interval was optimized by searching the narrowest QRS obtained within the fusion band during left ventricular (LV) pacing. The VV interval was then adjusted, comparing QRS duration in simultaneous biventricular, LV preexcitation (-30 milliseconds), right ventricular (RV) preexcitation (-30 milliseconds) and LV-only pacing. A substudy in 31 patients evaluated the invasive LV +dP/dtmax . The best fusion-optimized AV interval was 136 ± 30 milliseconds during atrial sensing and 192 ± 35 milliseconds during atrial pacing. The best QRS was obtained with simultaneous biventricular pacing in 28 patients (37%), LV preexcitation in 22 (29%), LV-only in 20 (26%), and RV preexcitation in 6 (8%). Baseline QRS was shortened more by FOI (59 ± 19 milliseconds) than by nominal settings (40 ± 21 milliseconds; P < 0.001). Sixty-five patients (86%) showed >10% shortening of the baseline QRS with FOI; none prolonged the QRS duration by FOI compared to nominal settings. All echocardiographic asynchrony parameters were corrected by FOI. Baseline +dP/dtmax improvement was greater in FOI (127 ± 95 mmHg/seconds) than in nominal settings (102 ± 71 mmHg/seconds; P = 0.05). CONCLUSION: The FOI method is feasible, further reduces QRS duration, and improves acute hemodynamic response compared to nominal programming of CRT.
BACKGROUND: Optimization of atrioventricular (AV) and interventricular (VV) intervals may improve cardiac resynchronization therapy (CRT) response but is a complex task. Fusion with intrinsic conduction may increase the benefit of CRT. The aim was to describe fusion-optimized intervals (FOI), a new method of optimizing CRT based on QRS duration. METHODS AND RESULTS: Seventy-six consecutive patients with preserved AV conduction who received CRT were prospectively included. The AV interval was optimized by searching the narrowest QRS obtained within the fusion band during left ventricular (LV) pacing. The VV interval was then adjusted, comparing QRS duration in simultaneous biventricular, LV preexcitation (-30 milliseconds), right ventricular (RV) preexcitation (-30 milliseconds) and LV-only pacing. A substudy in 31 patients evaluated the invasive LV +dP/dtmax . The best fusion-optimized AV interval was 136 ± 30 milliseconds during atrial sensing and 192 ± 35 milliseconds during atrial pacing. The best QRS was obtained with simultaneous biventricular pacing in 28 patients (37%), LV preexcitation in 22 (29%), LV-only in 20 (26%), and RV preexcitation in 6 (8%). Baseline QRS was shortened more by FOI (59 ± 19 milliseconds) than by nominal settings (40 ± 21 milliseconds; P < 0.001). Sixty-five patients (86%) showed >10% shortening of the baseline QRS with FOI; none prolonged the QRS duration by FOI compared to nominal settings. All echocardiographic asynchrony parameters were corrected by FOI. Baseline +dP/dtmax improvement was greater in FOI (127 ± 95 mmHg/seconds) than in nominal settings (102 ± 71 mmHg/seconds; P = 0.05). CONCLUSION: The FOI method is feasible, further reduces QRS duration, and improves acute hemodynamic response compared to nominal programming of CRT.
Authors: Caroline J M van Deursen; Liliane Wecke; Wouter M van Everdingen; Marcus Ståhlberg; Michel H G Janssen; Frieder Braunschweig; Lennart Bergfeldt; Harry J G M Crijns; Kevin Vernooy; Frits W Prinzen Journal: J Cardiovasc Transl Res Date: 2015-03-06 Impact factor: 4.132
Authors: Pavel Jurak; Josef Halamek; Jaroslav Meluzin; Filip Plesinger; Tereza Postranecka; Jolana Lipoldova; Miroslav Novak; Vlastimil Vondra; Ivo Viscor; Ladislav Soukup; Petr Klimes; Petr Vesely; Josef Sumbera; Karel Zeman; Roshini S Asirvatham; Jason Tri; Samuel J Asirvatham; Pavel Leinveber Journal: J Interv Card Electrophysiol Date: 2017-07-10 Impact factor: 1.900
Authors: Niraj Varma; David O'Donnell; Mohammed Bassiouny; Philippe Ritter; Carlo Pappone; Jan Mangual; Daniel Cantillon; Nima Badie; Bernard Thibault; Brian Wisnoskey Journal: J Am Heart Assoc Date: 2018-02-06 Impact factor: 5.501
Authors: Siana Jones; Joost Lumens; S M Afzal Sohaib; Judith A Finegold; Prapa Kanagaratnam; Mark Tanner; Edward Duncan; Philip Moore; Francisco Leyva; Mike Frenneaux; Mark Mason; Alun D Hughes; Darrel P Francis; Zachary I Whinnett Journal: Europace Date: 2017-07-01 Impact factor: 5.214
Authors: Peter H Waddingham; Jan Mangual; Michele Orini; Nima Badie; Luke McSpadden; Pier D Lambiase; Anthony W C Chow Journal: HeartRhythm Case Rep Date: 2021-09-29
Authors: Valter Bianchi; Alfonso R Martiniello; Jan Mangual; Vincenzo Tavoletta; Gianni Pedrizzetti; Giovanni Tonti; Valentina Maria Caso; Pio Caso; Antonio D'Onofrio Journal: J Interv Card Electrophysiol Date: 2021-01-20 Impact factor: 1.900
Authors: Ahmed AlTurki; Pedro Y Lima; Martin L Bernier; Daniel Garcia; Alejandro Vidal; Bruno Toscani; Sergio Diaz; Mauricio Montemezzo; Alaa Al-Dossari; Tomy Hadjis; Jacqueline Joza; Vidal Essebag Journal: CJC Open Date: 2020-01-21